STALLION PHARMACEUTICALS products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer specializing in dedicated antibiotic manufacturing, including penicillin and carbapenem production.
STALLION PHARMACEUTICALS products in Pakistan
STALLION PHARMACEUTICALS PVT LTD has 45 medicine presentations registered in Pakistan under 17 brands, covering 13 generic medicines. Most of its products are in Anti-infectives, Vitamins, minerals & nutrition and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Stamentin (Amoxicillin + clavulanic acid), Stamox (Amoxicillin), Ampistal (Ampicillin) and Stalbid (Ceftriaxone). 45 products have an official DRAP price on MedInfoBase. See all 17 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Stallion Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 187/5-D, Commercial Broadway, DHA Phase VIII, Lahore, Pakistan
- Website
- stallionpharma.com ↗
- Phone
- +92 42 35297647-8
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where STALLION PHARMACEUTICALS PVT LTD is priced against the market
36 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Acyclostin | Aciclovir | 250 mg | Lyophilized powder for injection | 1's | 106467 | PKR 585.27 | PKR 585.27/vial/unit | No comparator |
| Acyclostin | Aciclovir | 500 mg | Lyophilized injection | 1's | 106469 | PKR 975.44 | PKR 975.44/vial/unit | 🔒 Pharma Pro |
| Ampistal | Ampicillin | 125 mg/5 mL | Suspension | 60ml | 077228 | PKR 96.05 | PKR 1.60/mL | 🔒 Pharma Pro |
| Ampistal | Ampicillin | 250 mg | Capsule | 100’S | 077241 | PKR 327.90 | PKR 3.28/capsule | 🔒 Pharma Pro |
| Ampistal | Ampicillin | 500 mg | Capsule | 100’S | 077242 | PKR 604.03 | PKR 6.04/capsule | 🔒 Pharma Pro |
| Ampistal | Ampicillin | 500 mg | Injection | 10'S Vials | 079721 | PKR 396.93 | PKR 39.69/vial/unit | 🔒 Pharma Pro |
| IME | Cefixime | 400 mg | Capsule | 5's | 106477 | PKR 487.71 | PKR 97.54/capsule | 🔒 Pharma Pro |
| IME | Cefixime | 200 mg/5 mL | Suspension | 30ml | 106478 | PKR 359.40 | PKR 11.98/mL | 🔒 Pharma Pro |
| Merostin | Meropenem | 500 mg | Injection | 1 Vial | 080836 | PKR 1,035.47 | PKR 1,035.47/vial/unit | 🔒 Pharma Pro |
| Merostin | Meropenem | 1 g | Injection | 1 Vial | 080837 | PKR 1,898.36 | PKR 1,898.36/vial/unit | 🔒 Pharma Pro |
| Pentostal 40mg Lyophilized InjectionRegistry verified | Pantoprazole (as sodium) | — | — | — | 106465Official source ↗ | No indexed price | — | — |
| Stabactum 1gm InjectionRegistry verified | Cefoperazone Sodium eq. to Cefoperazone, Sulbactum Sodium eq. to Sulbactum | — | — | — | 129524Official source ↗ | No indexed price | — | — |
| Staclox 250 | Ampicillin + Cloxacillin | 125 mg + 125 mg | Capsule | 100'S | 077243 | PKR 345.15 | PKR 3.45/capsule | 🔒 Pharma Pro |
| Staclox 500 | Ampicillin + Cloxacillin | 250 mg + 250 mg | Capsule | 100’S | 077244 | PKR 517.74 | PKR 5.18/capsule | 🔒 Pharma Pro |
| Staclox 500 | Ampicillin + Cloxacillin | 250 mg + 250 mg | Injection | 10'S Vials | 086386 | PKR 406.90 | PKR 40.69/vial/unit | 🔒 Pharma Pro |
| Staclox Oral | Ampicillin + Cloxacillin | 60 mg + 30 mg | Oral drops | 20ml | 077230 | PKR 93.20 | PKR 4.66/mL | 🔒 Pharma Pro |
| Staclox Susp | Ampicillin + Cloxacillin | 125 mg + 125 mg / 5 mL | Suspension | 60ml | 077231 | PKR 51.77 | PKR 0.86/mL | No comparator |
| Stacolmi | Colistimethate sodium | 1 MIU | Injection | 1's | 106475 | PKR 2,401.09 | PKR 2,401.09/vial/unit | 🔒 Pharma Pro |
| Staesso Lyophilized Injection 40mgRegistry verified | Esomeprazole as sodium | — | — | — | 106468Official source ↗ | No indexed price | — | — |
| Stal-D3 | Cholecalciferol | 5 mg | Injection | 5's | 106476 | PKR 659.72 | PKR 131.94/vial/unit | 🔒 Pharma Pro |
| Stal-D3 | Cholecalciferol | 5 mg | Injection | 1's | 106476 | PKR 165.07 | PKR 165.07/vial/unit | 🔒 Pharma Pro |
| Stalbid | Ceftriaxone | 1 g | Injection | 1's | 106472 | PKR 481.72 | PKR 481.72/vial/unit | 🔒 Pharma Pro |
| Stalbid | Ceftriaxone | 500 mg | Injection | 1's | 106473 | PKR 255.11 | PKR 255.11/vial/unit | 🔒 Pharma Pro |
| Stalbid | Ceftriaxone | 250 mg | Injection | 1's | 106474 | PKR 151.56 | PKR 151.56/vial/unit | 🔒 Pharma Pro |
| Stallo | Omeprazole | 40 mg | Lyophilized powder for injection | 1's | 106466 | PKR 450.21 | PKR 450.21/vial/unit | 🔒 Pharma Pro |
| Stallo 20mg CapsuleRegistry verified | Omeprazole (as enteric coated pellets 8.5%) | — | — | — | 124338Official source ↗ | No indexed price | — | — |
| Stallo 40mg CapsuleRegistry verified | Omeprazole (as enteric coated pellets 8.5%) | — | — | — | 124339Official source ↗ | No indexed price | — | — |
| Stamentin | Amoxicillin + clavulanic acid | 125 mg/5 mL + 31.25 mg/5 mL | Suspension | 90ml | 077223 | PKR 222.36 | PKR 2.47/mL | No comparator |
| Stamentin | Amoxicillin + clavulanic acid | 125 mg/5 mL + 31.25 mg/5 mL | Suspension | 60ml | 077223 | PKR 172.56 | PKR 2.88/mL | No comparator |
| Stamentin | Amoxicillin + clavulanic acid | 250 mg + 62.5 mg / 5 mL | Suspension | 60ml | 077224 | PKR 271.00 | PKR 4.52/mL | 🔒 Pharma Pro |
| Stamentin | Amoxicillin + clavulanic acid | 250 mg + 62.5 mg/5 mL | Suspension | 90ml | 077224 | PKR 361.33 | PKR 4.01/mL | 🔒 Pharma Pro |
| Stamentin | Amoxicillin + clavulanic acid | 50 mg + 12.5 mg / mL | Oral drops | 10ml | 077225 | PKR 103.55 | PKR 10.36/mL | 🔒 Pharma Pro |
| Stamentin | Amoxicillin + clavulanic acid | 500 mg + 100 mg | Injection | 1 Vial | 077233 | PKR 172.58 | PKR 172.58/vial/unit | 🔒 Pharma Pro |
| Stamentin | Amoxicillin + clavulanic acid | 1 g + 200 mg | Injection | 1 Vial | 077234 | PKR 293.39 | PKR 293.39/vial/unit | 🔒 Pharma Pro |
| Stamentin | Amoxicillin + clavulanic acid | 500 mg + 125 mg | Tablet | 6's | 121449 | PKR 244.36 | PKR 40.73/tablet | 🔒 Pharma Pro |
| Stamentin | Amoxicillin + clavulanic acid | 200 mg + 125 mg | Tablet | 6's | 121450 | PKR 187.61 | PKR 31.27/tablet | No comparator |
| Stamentin | Amoxicillin + clavulanic acid | 875 mg + 125 mg | Tablet | 6's | 121451 | PKR 309.22 | PKR 51.54/tablet | 🔒 Pharma Pro |
| Stamentin DUO | Amoxicillin + clavulanic acid | 400.00 mg + 57.00 mg/5 mL | Suspension | 70ml | 077247 | PKR 349.75 | PKR 5.00/mL | No comparator |
| Stamentin DUO | Amoxicillin + clavulanic acid | 400.00 mg + 57.00 mg/5 mL | Suspension | 35ml | 077247 | PKR 187.61 | PKR 5.36/mL | No comparator |
| Stamox | Amoxicillin | 125 mg/5 mL | Suspension | 90ml | 077226 | PKR 136.66 | PKR 1.52/mL | 🔒 Pharma Pro |
| Stamox | Amoxicillin | 125 mg/5 mL | Suspension | 60ml | 077226 | PKR 91.49 | PKR 1.52/mL | 🔒 Pharma Pro |
| Stamox | Amoxicillin | 250 mg/5 mL | Suspension | 90ml | 077227 | PKR 202.67 | PKR 2.25/mL | 🔒 Pharma Pro |
| Stamox | Amoxicillin | 250 mg/5 mL | Suspension | 60ml | 077227 | PKR 134.34 | PKR 2.24/mL | 🔒 Pharma Pro |
| Stamox | Amoxicillin | 250 mg | Capsule | 100’S | 077237 | PKR 1,129.16 | PKR 11.29/capsule | 🔒 Pharma Pro |
| Stamox | Amoxicillin | 500 mg | Capsule | 100’S | 077238 | PKR 1,995.43 | PKR 19.95/capsule | 🔒 Pharma Pro |
| Stamox | Amoxicillin | 500 mg | Injection | 10'S Vials | 078879 | PKR 586.76 | PKR 58.68/vial/unit | 🔒 Pharma Pro |
| Stapime 1gm InjectionRegistry verified | Cefepime HCL with L-Arginine as Cefepime | — | — | — | 129622Official source ↗ | No indexed price | — | — |
| Stapime 500mg InjectionRegistry verified | Cefepime HCl with L-Arginine eq. to Cefepime | — | — | — | 129621Official source ↗ | No indexed price | — | — |
| Stavomycin | Vancomycin | 1 g | Lyophilized powder for injection | 1's | 106470 | PKR 1,695.77 | PKR 1,695.77/vial/unit | 🔒 Pharma Pro |
| Stavomycin | Vancomycin | 500 mg | Lyophilized injection | 1's | 106471 | PKR 1,050.47 | PKR 1,050.47/vial/unit | No comparator |
All 17 STALLION PHARMACEUTICALS brands in Pakistan
- Acyclostin Aciclovir · 250 mg injection, 500 mg injection
- Ampistal Ampicillin · 125 mg/5 mL suspension, 250 mg capsule, 500 mg injection
- IME Cefixime · 200 mg/5 mL suspension, 400 mg capsule
- Merostin Meropenem · 1 g injection, 500 mg injection
- Staclox 250 Ampicillin + Cloxacillin · 125 mg + 125 mg capsule
- Staclox 500 Ampicillin + Cloxacillin · 250 mg + 250 mg injection, 250 mg + 250 mg capsule
- Staclox Oral Ampicillin + Cloxacillin · 60 mg + 30 mg drops
- Staclox Susp Ampicillin + Cloxacillin · 125 mg + 125 mg / 5 mL suspension
- Stacolmi Colistimethate sodium · 1 MIU injection
- Stal-D3 Cholecalciferol · 5 mg injection
- Stalbid Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Stallo Omeprazole · 40 mg injection
- Stamentin Amoxicillin + clavulanic acid · 1 g + 200 mg injection, 125 mg/5 mL + 31.25 mg/5 mL suspension, 200 mg + 125 mg tablet
- Stamentin DUO Amoxicillin + clavulanic acid · 400.00 mg + 57.00 mg/5 mL suspension
- Stamox Amoxicillin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Stavomycin Vancomycin · 1 g injection, 500 mg injection
- Talzon Piperacillin + tazobactam · 2 g + 250 mg injection, 4 g + 500 mg injection
STALLION PHARMACEUTICALS: common questions
How many products does STALLION PHARMACEUTICALS have in Pakistan?
STALLION PHARMACEUTICALS PVT LTD has 45 registered medicine presentations in Pakistan, sold under 17 brands and covering 13 generic medicines.
What are the main brands of STALLION PHARMACEUTICALS?
By number of registered strengths and packs, its largest brands are Stamentin (Amoxicillin + clavulanic acid), Stamox (Amoxicillin), Ampistal (Ampicillin), Stalbid (Ceftriaxone) and Acyclostin (Aciclovir). This is not a sales ranking.
Which therapy areas does STALLION PHARMACEUTICALS cover?
The most products are in Anti-infectives (42), Vitamins, minerals & nutrition (2) and Gastrointestinal & hepatology (1).
Where can I see STALLION PHARMACEUTICALS medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.